THE INFLUENCE OF MONOTHERAPY WITH ENAM ON THE OVERALL CORONARY RISK: DYNAMICS OF CORRECTABLE CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH METABOLIC SYNDROME

THE INFLUENCE OF MONOTHERAPY WITH ENAM ON THE OVERALL CORONARY RISK: DYNAMICS OF CORRECTABLE CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH METABOLIC SYNDROME

The influence of monotherapy with enam on the overall coronary risk: dynamics of correctable cardiovascular risk factors in patients with metabolic syndrome.

Saved in:

Bibliographic Details
Main Authors:	M. N. Mamedov, O. V. Kosmatova, L. A. Hadipash, N. V. Kiseleva, R. G. Oganov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2002-02-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2009
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

AMELX and ENAM Polymorphisms and Dental Caries
by: Mohammad Reza Khami, et al.
Published: (2022-01-01)

Cardiovascular risk, metabolic disturbances, and the choice of antihypertensive therapy
by: M. N. Mamedov, et al.
Published: (2011-08-01)

Cardiovascular-kidney-metabolic syndrome — a new concept of the association of risk factors and metabolic disorders within the cardiovascular and renal continuum. View on the issue
by: G. G. Arabidze, et al.
Published: (2024-06-01)

Risk factors for cardiovascular diseases and coronary artery disease among military population
by: A. E. Masimova, et al.
Published: (2021-02-01)

THE DAILY PROFILE OF BLOOD PRESSURE IN METABOLIC SYNDROME: COMPARABLE ANALYSIS OF THE EFFICACY OF MONOTHERAPY WITH ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY
by: M. N. Mamedov, et al.
Published: (2016-01-01)

Reconstruction of the interior of the Saint Salvator abbey of Ename around 1290
by: Carlotta Capurro, et al.
Published: (2014-10-01)

ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK
by: M. N. Kovrigina, et al.
Published: (2015-12-01)

RISK STRATIFICATION OF POSTOPERATIVE CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ACUTE CORONARY SYNDROM
by: N. A. Shibeko, et al.
Published: (2013-06-01)

New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors
by: V. V. Syvolap, et al.
Published: (2014-04-01)

RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME
by: N. V. Perova, et al.
Published: (2015-09-01)

Atorvastatin effectiveness in dyslipidemia correction among coronary heart disease and arterial hypertension patients with high risk of cardiovascular complications
by: E. V. Minakov, et al.
Published: (2007-10-01)

Relationship between microplastics and cardiovascular risk factors
by: M. N. Mamedov, et al.
Published: (2024-07-01)

Obesity and pregnancy: cardiovascular and metabolic risks
by: N. G. Veselovskaya, et al.
Published: (2019-05-01)

EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE
by: M. N. Mamedov, et al.
Published: (2016-01-01)

Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma
by: Jack Patrick Gleeson, et al.
Published: (2020-01-01)

Coffee and cardiovascular risk: what is new?
by: G. Ya. Maslennikova, et al.
Published: (2009-08-01)

Associations of absolute risk of osteoporotic fractures (FRAX®) and total cardiovascular risk (SCORE) in urban population of the Russian Federation
by: M. A. Myagkova, et al.
Published: (2019-11-01)

Modifiable Coronary Risk Factors and Global Cardiovascular Risk
by: Julio Armando Sánchez Delgado, et al.
Published: (2021-06-01)

Cardiovascular risk after total thyroidectomy in patients with differentiated thyroid carcinoma undergoing levothyroxine replacement monotherapy
by: Martina Pucci, et al.
Published: (2025-08-01)

Testosterone undecanoate effects on cardiovascular risk factors in men with metabolic syndrome
by: A. L. Vertkin, et al.
Published: (2008-10-01)

The Impact Of Online Marketing Using Influencer Services In Sungai Enam Otak-Otak Village, Indonesia
by: Bayti Nur, et al.
Published: (2024-01-01)

Ten-year dynamics of risk factors and total cardiovascular risk in а cohort of male intellectual workers
by: N. A. Chepurina, et al.
Published: (2008-12-01)

Perimenopause period and menopause: cardiovascular and metabolic risks
by: V. H. Siusiuka, et al.
Published: (2024-10-01)

Total cardiovascular risk: what do the doctors know?
by: N. A. Chepurina, et al.
Published: (2010-10-01)

MARKERS OF ACCELERATED CONVERSION OF DIABETES MELLITUS IN VARIOUS CARDIOVASCULAR RISK PATIENTS
by: M. N. Mamedov, et al.
Published: (2016-12-01)

COMPARISON OF EFFECTS OF ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY ON INSULIN RESISTANCE, ENDOTHELIUM FUNCTION, MARKERS OF INFLAMMATION AND PLATELET ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME
by: M. N. Mamedov, et al.
Published: (2016-01-01)

The risk of coronary artery disease in patients with type 2 diabetes mellitus and metabolic syndrome
by: N.V. Chmyr, et al.
Published: (2024-06-01)

Coronary heart disease and risk factors in elderly population
by: A. E. Imaeva, et al.
Published: (2016-04-01)

OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT
by: I. I. Polskaya, et al.
Published: (2017-09-01)

WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL
by: M. N. Mamedov, et al.
Published: (2016-01-01)

Association of cardiovascular and fracture risks in women without clinical manifestations of atherosclerosis
by: I. A. Skripnikova, et al.
Published: (2020-12-01)

Combined lipid-lowering and antihypertensive therapy effects on hemostasis in metabolic sydrome patients
by: L. A. Ratnikova, et al.
Published: (2006-04-01)

Perlindungan Hukum Masyarakat Terhadap Kelalaian Pengelolaan Sampah di TPA Parit Enam Kota Pangkalpinang
by: Fuji Kurniawan, et al.
Published: (2024-11-01)

Restenosis risk factors after coronary stenting in metabolic syndrome patients
by: N. M. Danilov, et al.
Published: (2007-04-01)

Associations of an overall healthy lifestyle with the risk of metabolic dysfunction-associated fatty liver disease
by: Caimei Yuan, et al.
Published: (2024-11-01)

Cardiovascular risk stratification in elderly men with coronary heart disease
by: E. G. Volkova, et al.
Published: (2008-12-01)

Dietary Patterns in Patients with Coronary Artery Disease at Very High Cardiovascular Risk
by: Kochegura, T.N., et al.
Published: (2025-06-01)

Strategies and methods for the correction of obesity and associated cardiovascular risk
by: T. Yu. Kuznetsova, et al.
Published: (2019-05-01)

Association of smoking with coronary artery disease depending on other cardiovascular risk factors
by: E. D. Bazdyrev, et al.
Published: (2021-04-01)

Features of metabolic correction in patients after percutaneous coronary intervention for acute coronary syndrome without ST elevation
by: L.S. Kholopov, et al.
Published: (2016-03-01)